MedPath

Epirus Biopharmaceuticals (Switzerland) GmbH

🇨🇭Switzerland
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study

Phase 3
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2016-02-17
Last Posted Date
2016-02-17
Lead Sponsor
Epirus Biopharmaceuticals (Switzerland) GmbH
Target Recruit Count
548
Registration Number
NCT02683564

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.